Publisher
Springer Science and Business Media LLC
Subject
Urology,Obstetrics and Gynecology
Reference11 articles.
1. US Food and Drug Administration. FDA takes action to protect women’s health, orders manufacturers of surgical mesh intended for transvaginal repair of pelvic organ prolapse to stop selling all devices. 2017. https://www.fda.gov/news-events/press-announcements/fda-takes-action-protect-womens-health-orders-manufacturers-surgical-mesh-intended-transvaginal. Accessed 27 Jan 2021
2. Ng-Stollmann N, Funfgeld C, Gabriel B, Niesel A. The international discussion and the new regulations concerning transvaginal mesh implants in pelvic organ prolapse surgery. Int Urogynecol J. 2020;31(10):1997–2002. https://doi.org/10.1007/s00192-020-04407-0.
3. Glazener CM, Breeman S, Elders A, et al. Mesh, graft, or standard repair for women having primary transvaginal anterior or posterior compartment prolapse surgery: two parallel-group, multicentre, randomised, controlled trials (PROSPECT). Lancet. 2017;389(10067):381–92. https://doi.org/10.1016/S0140-6736(16)31596-3.
4. Winkelman WD, Macharia A, Bharadwa S, Bharadwaj M, Hacker MR, Rosenblatt PL. Composite outcomes after posterior colporrhaphy with and without biologic graft augmentation. Female Pelvic Med Reconstr Surg. 2021;27(2):e414–7. https://doi.org/10.1097/SPV.00000000000009495.
5. Brown BN, Londono R, Tottey S, et al. Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials. Acta Biomater. 2012;8(3):978–87. https://doi.org/10.1016/j.actbio.2011.11.031.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献